Marshall Kirsch
Neurology · Festus, MONPI 1699301549
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $864, 8.4 times the $102 reported in 2022.
Across 112 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$327
- Pfizer$235
- Jazz Pharmaceuticals Inc.$223
- EMD Serono, Inc.$222
- SK Life Science, Inc.$183
- Novartis$160
- plus $498 from 14 others
What the payments were for
- Food & beverage$1,848100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 20 | $327 |
| Pfizer | 21 | $235 |
| Jazz Pharmaceuticals Inc. | 11 | $223 |
| EMD Serono, Inc. | 15 | $222 |
| SK Life Science, Inc. | 10 | $183 |
| Novartis | 9 | $160 |
| Neurelis, Inc. | 7 | $122 |
| AbbVie | 3 | $65 |
| Genentech USA, Inc. | 3 | $55 |
| Sanofi | 2 | $38 |
| AstraZeneca(2 entities) | 2 | $38 |
| Biocodex, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Argenx US, Inc. | 1 | $24 |
| Otter Pharmaceuticals, LLC | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| TG Therapeutics, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
How this compares
$1,848 in reported general payments places this provider in the 55th percentile of 381 neurology providers in Missouri.
Other neurology in Festus
- William RosenfeldChesterfield$2.1M
- Barry SingerSaint Louis$1.9M
- Mark TullmanSaint Louis$1.5M
- Curtis SchreiberBolivar$882K
- Robert NaismithSaint Louis$677K
- Daniel MattsonBridgeton$451K
- Siddharth KaulBridgeton$387K
- Barbara GreenChesterfield$352K
- Steven KosaNorth Kansas City$323K
- Seth HepnerBridgeton$285K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.